Fennec Pharmaceuticals Inc (FENC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2021 | 12-2020 | 09-2020 | 06-2020 | 03-2020 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 26,751 | 30,344 | 33,166 | 38,729 | 9,901 |
| Other current assets | 455 | 276 | 4 | 4 | 2 |
| TOTAL | $27,825 | $31,417 | $34,070 | $38,899 | $10,123 |
| Non-Current Assets | |||||
| Other Non-Current Assets | 0 | 0 | 0 | 417 | 245 |
| TOTAL | $N/A | $N/A | $0 | $417 | $245 |
| Total Assets | $27,825 | $31,417 | $34,070 | $39,316 | $10,368 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 2,508 | 1,571 | 2,684 | 2,755 | 1,675 |
| Accrued Expenses | 384 | 776 | 201 | 435 | 232 |
| TOTAL | $2,892 | $2,347 | $2,885 | $3,190 | $1,907 |
| Non-Current Liabilities | |||||
| TOTAL | $N/A | $N/A | $N/A | $N/A | $N/A |
| Total Liabilities | $2,892 | $2,347 | $2,885 | $3,190 | $1,907 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 26,003 | 26,003 | 25,810 | 25,356 | 25,356 |
| Common Shares | 140,733 | 140,733 | 139,732 | 138,359 | 106,392 |
| Retained earnings | -166,873 | -162,140 | -158,902 | -152,702 | -147,857 |
| Other shareholders' equity | 1,243 | 1,243 | 1,243 | 1,243 | 1,243 |
| TOTAL | $24,933 | $29,070 | $31,185 | $36,126 | $8,461 |
| Total Liabilities And Equity | $27,825 | $31,417 | $34,070 | $39,316 | $10,368 |